Paul L. Berns, 10% Owner at Lyell Immunopharma, Inc. (LYEL), bought 488,090 shares at $25.61 ($12.5M) on 2026-03-06, disclosed to the SEC on 2026-03-09.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| Filing → |
| NMRA | SELL | 2025-02-20 | $23K | — | Filing → |
| MTSR | BUY | 2025-02-03 | $14.2M | — | Filing → |
| JAZZ | SELL | 2021-08-09 | $223K | — | Filing → |